Scinai Immunotherapeutics Ltd - ADR

NASDAQ:SCNI  
2.32
+0.02 (+0.65%)
7:08:22 PM EDT: $2.24 -0.08 (-3.24%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Scinai Immunotherapeutics Ltd - ADR Stock, NASDAQ:SCNI

Jerusalem BioPark, Hadassah Ein Kerem Campus, Jerusalem, Jerusalem 74036
Israel
Phone: +972.302.930.2529
Number of Employees: 31
http://www.scinai.com

Description

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.